Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
The American Journal of Medicine|December 18, 2003
Thiazolidinedione regulation of smooth muscle cell proliferationDennis Bruemmer, Ronald E LawCurrent Drug Targets. Cardiovascular & Haematological Disorders|March 1, 2006
Liver x receptors: potential novel targets in cardiovascular diseasesDennis Bruemmer, Ronald E LawAmerican Journal of Physiology. Endocrinology and Metabolism|January 8, 2005
PPARgamma-mediated insulin sensitization: the importance of fat versus muscleUlrich Kintscher, Ronald E LawClinical Cardiology|October 9, 2004
Will the potential of peroxisome proliferator-activated receptor agonists be realized in the clinical setting?Florian Blaschke, Dennis Bruemmer, Ronald E LawFrontiers in Bioscience : a Journal and Virtual Library|February 10, 2004
Angiotensin II, PPAR-gamma and atherosclerosisUlrich Kintscher, Christopher J Lyon, Ronald E LawJournal of Diabetes and Its Complications|March 2, 2002
Vascular protective effects by activation of nuclear receptor PPARgammaShu Wakino, Ronald E Law, Willa A HsuehEndocrinology|May 15, 2003
Minireview: adiposity, inflammation, and atherogenesisChristopher J Lyon, Ronald E Law, Willa A HsuehVascular Pharmacology|June 3, 2006
Vascular effects of TZDs: new implicationsFlorian Blaschke, Robert Spanheimer, Mehmood Khan, et al.Biochemical and Biophysical Research Communications|May 24, 2003
p38 MAP kinase negatively regulates angiotensin II-mediated effects on cell cycle molecules in human coronary smooth muscle cellsUlrich Kintscher, Dennis Bruemmer, Florian Blaschke, et al.PPAR Research|March 20, 2010
A Dominant-Negative PPARgamma Mutant Promotes Cell Cycle Progression and Cell Growth in Vascular Smooth Muscle CellsJoey Z Liu, Christopher J Lyon, Willa A Hsueh, et al.Pageof 4